Can Trumpoti lower prescription drug prices? Here’s why American drug costs are so high. star-news.press/wp

President Trump signed the executive order Monday who will try to make the cost of some medications in the United States – but why are drug prices so high to start?

Americans pay an average of almost three times more for prescription drugs such as people in other high-income countries such as Great Britain, Germany or France, in words Report 2024 Published a non-profit research of Rand research. For some medications, the difference in costs is even steeply. The month of insulin, for example, costs about $ 100 in the US, compared to only about $ 10 in France, Rand was found.

In a large part it comes down to pricing negotiations.

“Talk about opposites with countries who are basically universal health care, where you have a government that pays for everything, negotiating for all medicines,” CBS news for public health KFF, said on Monday. “So when you have one player who negotiates on behalf of the whole population, you just have a lot of negotiating power.”

The closest comparison in the US is probably Medicare, the Federal Health Insurance Program for people older than 65, Gounder said, but it does not cover all Americans. In addition, the ability for Medicare to Negotiate drug prices It did not happen until the Law on Reducing Inflation 2022 was brought by the President Joe Biden and this allows only the negotiations “small works of all prescription drugs,” Gounder said.

Since now they have no universal health care, “we have no negotiators for our drug prices,” Gounder said.

Most Americans have private health insurance, and the prices payable for recipes are negotiated through managers or PBM pharmacy.

Theoretically, PBMS should help control the growth of drug prices due to their ability to negotiate the manufacturers and other economy options, according to Common Funda non-profit foundation that advocates for health capital.

“But PBMS have financial incentives that can contribute to the growth of drug prices, larger patients from pockets, and the closure of independent pharmacy in rural areas and low-income neighborhoods,” group on its website.

Last year, the Federal Trade Commission Called to managers for Behel – They are often described as a medium medicine on a prescription – to use full drug prices. PBMS has huge control over availability and drug costs, FTC said in the report published in July 2024. years.

In a newer January reportFTC said that three main PBM’s hiking costs for a wide range of body medications, including medications to treat heart disease and cancer. Some prices are marked hundreds and sometimes thousands of percentages, FTC has found.

Will Trump’s executive order help lower drug prices?

It is insecure if Mr. Trump’s executive order can make progress on drug prices and what would affect drugs.

Gounder pointed out a similar effort during the First Presidency, which applies only to medications that provided providers in hospitals and clinics through Medicare part B, which failed.

“The last time he suggested 2020. year, it was disputed in the federal courts and did not stand up,” Gounder said.

To really change how to negotiate in the USA in the US, the Congress should act, she said.

Plus “,” Pharmaceutical companies are among the largest lobbying lobbying in Washington, DC which, of course, opposed to this, “Gounder said.

The pharmaceutical industry claimed that lower prices would affect innovation and development of new drugs.

“Application of anti-tied access to other countries in a way – and payment – for drugs will be stopped in investments in American biotechnical companies, and ran into smaller American patients,” John F. Crowley said on Monday Monday.

Change how many influences of pharmaceutical companies also require the rank of congress in the form of campaign finance reform, Gounder said.

Patients for affordable drugs now, the national organization of patient advocacy, said in a statement that several aspects of the Lord Trump account asks questions.

“This executive stand is a step in the right direction, but without additional protective poles leaves space for pharmaceutical companies to continue playing the patient’s damage”, reading the statement. “The reality is: drugs that have set high prices in the USA, as the US policy allows them – unlike other high-income countries that negotiate lower prices.”